earticle

논문검색

Poster 13

Analytical Platform for Glycomic Characterization of Recombinant Erythropoietin Biotherapeutics and Biosimilars by Mass Spectrometry

초록

영어

Erythropoietin is a therapeutic glycoprotein that stimulates red blood cell production. The quality, safety, and potency of recombinant erythropoietins are determined largely by their glycosylation. Small variations in cell culture conditions can significantly affect the glycosylation, and therefore the efficacy, of recombinant erythropoietins. Thus, detailed glycomic analyses are necessary to assess biotherapeutic quality. We have developed a platform for qualitative and quantitative glycomic analysis of recombinant erythropoietins. The platform was used to profile native N-glycans from three different type erythropoietin a common form of recombinant erythropoietin. Darbepoetin alfa was found to contain an abundance of large, multi-antennary N-glycans with high levels of sialylation, O-acetylation, and dehydration. Results were verified by independent orthogonal analysis with both MALDI-TOF and nano-LC/Q-TOF MS. This platform may be applied to quality control and batch analysis of not only recombinant erythropoietin but also other complex, glycosylated biotherapeutics and biosimilars.

저자정보

  • Myung Jin Oh Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, 305-764 Korea
  • Serenus Hua Division of Mass Spectrometry Research, Korea Basic Science Institute, Ochang, Korea
  • Chan Young Han Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, 305 -764 Korea
  • Jong Shin Yoo Graduate School of Analytical Science and Technology, Chungnam National University, Division of Mass Spectrometry Research, Korea Basic Science Institute, Ochang, Korea
  • Hyun Joo An Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, 305-764 Korea

참고문헌

자료제공 : 네이버학술정보

    ※ 원문제공기관과의 협약에 따라 개인회원에게 무료로 제공됩니다.

    0개의 논문이 장바구니에 담겼습니다.